Sarah Porter Selected Research

Disintegrins

3/2006

ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah Porter Research Topics

Disease

3	Neoplasms (Cancer) 05/2012 - 04/2004
3	Breast Neoplasms (Breast Cancer) 09/2009 - 04/2004
1	Triploidy 10/2017
1	Squamous Cell Carcinoma of Head and Neck 05/2012
1	Osteoarthritis 01/2004

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 09/2009 - 04/2004
2	ThrombospondinsIBA 03/2006 - 04/2004
1	PolyphenolsIBA 05/2012
1	Thioredoxin Reductase 1IBA 05/2012
1	CurcuminIBA 05/2012
1	Messenger RNA (mRNA)IBA 09/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2009
1	Proteins (Proteins, Gene)FDA Link 09/2009
1	SuspensionsIBA 09/2009
1	Metalloproteases (Metalloproteinases)IBA 03/2006
1	DisintegrinsIBA 03/2006
1	Crotalus adamanteus proteinase II (adamalysin)IBA 04/2004
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2004
1	Matrix Metalloproteinases (MMPs)IBA 01/2004

Therapy/Procedure

1	Therapeutics 10/2017
1	Radiotherapy 05/2012